Industry Scores a Win as Watered-Down Version of Canada’s IRP Reform Unveiled in Final Guidelines, but Prices Will Nevertheless Decline
Description
Industry Scores a Win as Watered-Down Version of Canada’s IRP Reform Unveiled in Final Guidelines, but Prices Will Nevertheless Decline
Summary
Shortly after the release of Canada's long-awaited final guidelines for the implementation of its International Reference Pricing (IRP) system reform, GlobalData reflects on how the final reform compares to the original plans and where the real danger to the pharma industry lies as the new rules take effect.
Summary
Shortly after the release of Canada's long-awaited final guidelines for the implementation of its International Reference Pricing (IRP) system reform, GlobalData reflects on how the final reform compares to the original plans and where the real danger to the pharma industry lies as the new rules take effect.
Table of Contents
12 Pages
- Final guidelines for IRP reform implementation released
- The history of a much-delayed IRP reform
- Role of IRP in pricing process
- An unexpected positive for pharma in the final guidelines
- Is there more than meets the eye, and where does danger lurk for pharma?
- Outlook and implications
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
